Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: A prospective study

European Journal of Obstetrics Gynecology and Reproductive Biology

Volumn 103, Issue 2, 2002, Pages 140-145

  El Nemr, A ^a,b   Bhide, M ^a   Khalifa, Y ^a   Al Mizyen, E ^a   Gillott, C ^a   Lower, A M ^a   Al Shawaf, T ^a   Grudzinskas, J G ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b Al Mouwasat Hospital   (Saudi Arabia)

Author keywords

Controlled ovarian hyperstimulation; Gonadotrophin releasing hormone; IVF

Indexed keywords

BUSERELIN; GONADORELIN; LEUPRORELIN; NAFARELIN; DRUG DERIVATIVE; FERTILITY PROMOTING AGENT; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERTILIZATION IN VITRO; HEADACHE; HOT FLUSH; HUMAN; INFERTILITY; INFERTILITY THERAPY; IRRITABILITY; MAJOR CLINICAL STUDY; NOSE ALLERGY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; EMBRYO TRANSFER; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; OOCYTE; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; BUSERELIN; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; MENOTROPINS; NAFARELIN; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037054718     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00297-4     Document Type: Article

References (32)

1. Pituitary and hypothalamic hormones, principles of medical pharmacology
2. Induction of ovulation for in vitro fertilisation using buserelin and gonadotropins
3. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression
4. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonist during ovarian hyperstimulation for in-vitro fertilisation and embryo transfer
5. Randomized prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in-vitro fertilisation
6. The routine use of gonadotrophin-releasing hormone agonists prior to in-vitro fertilisation and gamete intra-fallopian transfer: a meta-analysis of randomized controlled trials
7. Management of failed cycles in IVF/GIFT programme with combination of a GnRH analogue and hMG
8. Effect of gonadotrophin-releasing hormone agonist on follicle and oocyte quality
9. Hypersecretion of luteinising hormone, infertility and miscarriage
10. Embryo quality and uterine receptivity in in-vitro fertilisation cycle with or without agonists of gonadotrophin-releasing hormone
11. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in assisted conception program
12. Ovarian stimulation protocol for in-vitro fertilisation with gonadotropin-releasing hormone agonist widens the implantation window
13. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in-vitro fertilisation
14. The comparison of early follicular and mid-luteal administration of long acting gonadotropin-releasing hormone agonist
15. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in-vitro fertilisation
16. Effect of age on response to human menopausal gonadotrophin stimulation
17. Improvement of in-vitro fertilisation after treatment with buserelin, an agonist of luteinizing hormone-releasing hormone
18. The influence of stimulation regimes and luteal phase support on the outcome of IVF
19. The value of GnRH therapy in IVF in women with unexplained infertility
20. Comparison between depot leuprorelin and daily buserelin in IVF
21. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a pospoctive randomised study
22. Comparison between nafarelin and leuprolide acetate for in-vitro fertilisation: preliminary clinical study
23. Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study
24. Pituitary down-regulation prior to in-vitro fertilisation and embryo transfer: a comparison between a single dose of zoladex and multiple daily doses of suprefact
25. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilisation-embryo transfer
26. The choice of a gonadotropin-releasing hormone analog influences outcome of in-vitro fertilization treatment
27. Psychosocial testing and pre-treatment of women for in-vitro fertilisation
28. Studies on psychosomatic implications of infertility-effects of emotional stress on fertilisation and implantation in in-vitro fertilisation
29. Is fertility problem stress different? The dynamics of stress in fertile and infertile couples
30. The comparison of two gonadotrophin-releasing hormone agonists in an in-vitro fertilization program
31. Nafarelin versus leuprolide in ovulation induction for in-vitro fertilization: a randomised clinical trial